Vanderbilt Breast Center at One Hundred Oaks — Nashville, Tennessee

Vanderbilt Breast Center at One Hundred Oaks is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt Breast Center at One Hundred Oaks has participated in 95 clinical trials with 65 currently active.

Therapeutic areas: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Breast Cancer.

Sponsors: National Cancer Institute (NCI), Daiichi Sankyo, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Breast Center at One Hundred Oaks?

Vanderbilt Breast Center at One Hundred Oaks has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Breast Center at One Hundred Oaks conducted?

Vanderbilt Breast Center at One Hundred Oaks has 95 clinical trials on record, with 65 currently active. Their work covers Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Breast Cancer.

Is Vanderbilt Breast Center at One Hundred Oaks accredited by Crixeo Health?

Vanderbilt Breast Center at One Hundred Oaks has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Breast Center at One Hundred Oaks?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.